These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2417747)

  • 1. Potential deleterious effects of inotropic agents in the therapy of chronic heart failure.
    Katz AM
    Circulation; 1986 Mar; 73(3 Pt 2):III184-90. PubMed ID: 2417747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New positive inotropic substances--true inotropy or peripheral effects?
    Wilmshurst P
    Z Kardiol; 1988; 77 Suppl 5():103-11. PubMed ID: 3066033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
    Uretsky BF; Valdes AM; Reddy PS
    Circulation; 1986 Mar; 73(3 Pt 2):III219-29. PubMed ID: 2935328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of novel inotropic agents in the treatment of heart failure.
    LeJemtel TH; Keren G; Reis D; Sonnenblick EH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 9():S47-54. PubMed ID: 2433542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effects of intravenous amrinone in patients with congestive heart failure.
    Goldstein RA
    Circulation; 1986 Mar; 73(3 Pt 2):III191-5. PubMed ID: 3510775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congestive heart failure--pathophysiology and medical treatment.
    Remme WJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S36-52. PubMed ID: 2422492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel approach to the development of positive inotropic agents for chronic heart failure.
    Packer M
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S52-6. PubMed ID: 8907131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inotropic therapy for heart failure: an evidence-based approach.
    Felker GM; O'Connor CM
    Am Heart J; 2001 Sep; 142(3):393-401. PubMed ID: 11526351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1.
    Colucci WS; Wright RF; Braunwald E
    N Engl J Med; 1986 Jan; 314(5):290-9. PubMed ID: 2867470
    [No Abstract]   [Full Text] [Related]  

  • 11. [Calcium sensitizer agents in heart failure therapy].
    Iwama Y; Takagi A
    Nihon Rinsho; 2007 May; 65 Suppl 5():61-5. PubMed ID: 17571366
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical use of inotropic therapy for heart failure: looking backward or forward? Part I: inotropic infusions during hospitalization.
    Stevenson LW
    Circulation; 2003 Jul; 108(3):367-72. PubMed ID: 12876135
    [No Abstract]   [Full Text] [Related]  

  • 13. Levosimendan: beyond its simple inotropic effect in heart failure.
    Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
    Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonglycoside inotropes in congestive heart failure. Are they beneficial or harmful?
    Chatterjee K; Wolfe CL; DeMarco T
    Cardiol Clin; 1994 Feb; 12(1):63-72. PubMed ID: 8181026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced relaxation and reduced positive inotropic effects of amrinone in ventricular muscle from cats with subacute heart failure. Implications for drug therapy.
    Bassett AL; Gaide MS; Lodge NJ; Cameron JS
    Adv Myocardiol; 1985; 6():629-36. PubMed ID: 2986264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium sensitizers in chronic heart failure: inotropic interventions-reservation to preservation.
    Teramura S; Yamakado T
    Cardiologia; 1998 Apr; 43(4):375-85. PubMed ID: 9659795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure.
    Petein M; Levine TB; Cohn JN
    Circulation; 1986 Mar; 73(3 Pt 2):III230-6. PubMed ID: 3510778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value and limitations of new cardiotonic agents].
    Grosgogeat Y; Komajda M
    Bull Acad Natl Med; 1989 Feb; 173(2):121-30; discussion 131. PubMed ID: 2670075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inotropic agents].
    Sasayama S
    Nihon Rinsho; 2003 May; 61(5):807-14. PubMed ID: 12755007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inotropic therapy is unsuccessful: wrong conceptual target or wrong therapeutic tools?
    Rapezzi C; Perugini E; Santi M; Bracchetti G; Branzi A
    Ital Heart J; 2003 May; 4 Suppl 2():22S-26S. PubMed ID: 14635366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.